Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths.

dc.contributor.author

Wu, Li-Tzy

dc.contributor.author

Schlenger, William E

dc.contributor.author

Galvin, Deborah M

dc.date.accessioned

2020-02-03T06:30:59Z

dc.date.available

2020-02-03T06:30:59Z

dc.date.issued

2006-09

dc.date.updated

2020-02-03T06:30:59Z

dc.description.abstract

The magnitude and the characteristics of the use of methamphetamine, MDMA (Ecstasy), LSD (d-lysergic acid diethylamide), ketamine, GHB (gamma-hydroxybutyrate), and flunitrazepam (Rohypnol) were examined in a probability sample of the U.S. civilian population that included multiethnic urban, suburban, and rural youths aged 16-23 (N=19,084).Data were drawn from the National Survey on Drug Use and Health (NSDUH). Logistic regression analyses were conducted to identify the characteristics associated with the use of each of these drugs and of multiple drugs.Approximately 20% of youths aged 16-23 reported having ever used one or more of these drugs. Less than 1% of club drug users used club drugs only, and 82% of them had ever used three or more drug classes. Females were more likely than males to report using multiple club drugs. Recent users of methamphetamine were most likely to be females and adolescents aged 16 or 17. Recent users of MDMA tended to be young adults aged 18-21 and residents of metropolitan areas. Most recent users of LSD were adolescents aged 16-19 and those in low-income families. Ketamine users were primarily employed youths. Staying in school and getting married were associated with decreased odds of club drug use. Club drug use was highly associated with the presence of criminal behaviors and recent alcohol abuse or dependence.Adolescents are more likely than young adults to use multiple drugs. The clustering of multidrug use and alcohol use disorder is a cause of concern.

dc.identifier

S0376-8716(06)00003-2

dc.identifier.issn

0376-8716

dc.identifier.issn

1879-0046

dc.identifier.uri

https://hdl.handle.net/10161/20041

dc.language

eng

dc.publisher

Elsevier BV

dc.relation.ispartof

Drug and alcohol dependence

dc.relation.isversionof

10.1016/j.drugalcdep.2006.01.002

dc.subject

Humans

dc.subject

Substance-Related Disorders

dc.subject

Methamphetamine

dc.subject

N-Methyl-3,4-methylenedioxyamphetamine

dc.subject

Sodium Oxybate

dc.subject

Ketamine

dc.subject

Lysergic Acid Diethylamide

dc.subject

Flunitrazepam

dc.subject

Data Collection

dc.subject

Incidence

dc.subject

Prevalence

dc.subject

Age of Onset

dc.subject

Demography

dc.subject

Adolescent

dc.subject

Adult

dc.subject

Female

dc.subject

Male

dc.title

Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths.

dc.type

Journal article

duke.contributor.orcid

Wu, Li-Tzy|0000-0002-5909-2259

pubs.begin-page

102

pubs.end-page

113

pubs.issue

1

pubs.organisational-group

School of Medicine

pubs.organisational-group

Duke

pubs.organisational-group

Center for Child and Family Policy

pubs.organisational-group

Sanford School of Public Policy

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Duke Institute for Brain Sciences

pubs.organisational-group

University Institutes and Centers

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Psychiatry & Behavioral Sciences, Social and Community Psychiatry

pubs.organisational-group

Psychiatry & Behavioral Sciences

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Medicine, General Internal Medicine

pubs.organisational-group

Medicine

pubs.publication-status

Published

pubs.volume

84

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Wu 2006 Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths..pdf
Size:
254.09 KB
Format:
Adobe Portable Document Format